Join us on February 20–21, 2025 in New York City Bar Association New York, NY, for essential insights into navigating AI’s legal and regulatory landscape in life sciences. Discover how AI is accelerating drug discovery, optimizing clinical trials, and enhancing disease diagnosis to bridge innovation with real-world healthcare.
Shaping the Future of the Life Sciences: The EU AI Act’s Impact
Navigating FDA and EMA Directives for AI in Life Sciences
AI Litigation Across the Lifecycle of Life Sciences Products: From Pre-Commercialization to Post-Market Risks
AI Governance and Regulatory Sandboxes: Testing Innovation in Life Sciences
The Future of AI in the Life Sciences: Post-Election Regulatory Shifts and Strategic
IP Protections for AI-Driven Innovations: Navigating Ownership and Inventorship Challenges in the Life Sciences
Forging Strategic AI Partnerships in the Life Sciences: Building Success from Research to Implementation
Navigating Data Privacy Challenges and AI in the Life Sciences: A Global Roadmap for the Digital Age
AI in Action: Enhancing Clinical Decision-Making with AI
